Strs Ohio Decreases Stake in Abbott Laboratories $ABT

Strs Ohio reduced its stake in Abbott Laboratories (NYSE:ABT) by 3.9% during the fourth quarter, selling 21,803 shares and now owning 544,394 shares valued at $68,207,000. Despite this, other institutional investors increased their positions, while Abbott Laboratories reported strong quarterly earnings, beating estimates, and announced a quarterly dividend. Analyst ratings for ABT are generally positive with a “Moderate Buy” consensus.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin